A 6-month controlled trial in diabetics with ischemic heart disease showed that empagliflozin attenuated both inflammation and systemic oxidative stress, resulting in clinically significant cardiovascular benefits (Ma et al., 2024)
I am building a fuller framework for this in AuDHD Unlocked, but the starting point is straightforward: how the two interact often matters more than how we separate them
Add links here when ready: Boca Raton, Miami, Aventura, Fort Lauderdale, Hollywood
Approval of the protocol and animal use were obtained from the institutional ethical committee
Kinjo T, Ham-Terhune J, Peloponese JM Jr, Jeang KT
if B12 levels were either at the high end of acceptable range, or higher than acceptable range, then the recommendation also included advice to review the frequency of the intervention and to consider changing from 3-monthly interventions to 6-monthly interventions